Skip to main content
SpringerLink
Log in

Immune Thrombocytopenia in Adolescents

  • Chapter
  • First Online:
Hematology in the Adolescent Female

  • 406 Accesses

Abstract

Immune thrombocytopenia (ITP) is an autoimmune condition defined as an isolated platelet count of <100,000/microL with a normal white blood cell count and hemoglobin concentration in the absence of identifiable and specific precipitants. ITP in adolescents is similar to ITP in adults and children in terms of diagnosis and presentation. The clinical course is a hybrid, with more patients requiring therapy, and many patients eventually achieving remission. Therapy is guided by bleeding symptoms, rather than absolute platelet counts, but also by prophylaxis against bleeding, given the increased physical activity in this age group. Careful attention should be paid to females with heavy menstrual bleeding. Lastly, the psychosocial aspects of care for patients in this vulnerable age group must be considered, with attention to aspects of independence and shared decision making.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kühne T, Imbach P, Bolton-Maggs PHB, Berchtold W, Blanchette V, Buchanan GR. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet. 2001;358(9299):2122–5. https://doi.org/10.1016/S0140-6736(01)07219-1.

    Article  PubMed  Google Scholar 

  2. Rosthøj S, Hedlund-Treutiger I, Rajantie J, et al. Duration and morbidity of newly diagnosed idiopathic. Most. 2003;143(3):302–7. http://www.ncbi.nlm.nih.gov/pubmed/14517509.

    Google Scholar 

  3. Kühne T, Buchanan GR, Zimmerman S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. J Pediatr. 2003;143(5):605–8. https://doi.org/10.1067/S0022-3476(03)00535-3.

    Article  PubMed  Google Scholar 

  4. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386–93. https://doi.org/10.1182/blood-2008-07-162503.

    Article  CAS  PubMed  Google Scholar 

  5. Zufferey A, Kapur R, Semple J. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017;6(2):16. https://doi.org/10.3390/jcm6020016.

    Article  CAS  PubMed Central  Google Scholar 

  6. Olsson B, Andersson PO, Jernås M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9(9):1123–4. https://doi.org/10.1038/nm921.

    Article  CAS  PubMed  Google Scholar 

  7. Khodadi E, Asnafi AA, Shahrabi S, Shahjahani M, Saki N. Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis. Ann Hematol. 2016;95(11):1765–76. https://doi.org/10.1007/s00277-016-2703-1.

    Article  CAS  PubMed  Google Scholar 

  8. Terrell DR, Beebe LA, Neas BR, Vesely SK, Segal JB, George JN. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012;87(9):848–52. https://doi.org/10.1002/ajh.23262.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood. 1999;94(3):909–13.

    Article  CAS  Google Scholar 

  10. Neylon AJ, Saunders PWG, Howard MR, Proctor SJ, Taylor PRA. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol. 2003;122(6):966–74. https://doi.org/10.1046/j.1365-2141.2003.04547.x.

    Article  PubMed  Google Scholar 

  11. Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190–207. https://doi.org/10.1182/blood-2010-08-302984.

    Article  CAS  PubMed  Google Scholar 

  12. Oncology PH, George JN, Cohen AR, Blanchette VS. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr. 2003;25(2):130–3.

    Google Scholar 

  13. Heitink-Pollé KMJ, Uiterwaal CSPM, Porcelijn L, et al. Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial. Blood. 2018;132(9):883–91. https://doi.org/10.1182/blood-2018-02-830844.

    Article  CAS  PubMed  Google Scholar 

  14. Glanz J, France E, Xu S, Hayes T, Hambidge S. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics. 2008;121(3):10–5. https://doi.org/10.1542/peds.2007-1129.

    Article  Google Scholar 

  15. Revel-Vilk S, Yacobovich J, Frank S, et al. Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months. J Pediatr. 2013;163(5):1335–9. https://doi.org/10.1016/j.jpeds.2013.06.018.

    Article  PubMed  Google Scholar 

  16. Cohen YC, Djuibegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med. 2000;160(11):1630–8. https://doi.org/10.1001/archinte.160.11.1630.

    Article  CAS  PubMed  Google Scholar 

  17. Kühne T, Berchtold W, Michaels LA, et al. Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the intercontinental cooperative immune thrombocytopenia study group. Haematologica. 2011;96(12):1831–7. https://doi.org/10.3324/haematol.2011.050799.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Neunert C, Noroozi N, Norman G, et al. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost. 2015;13(3):457–64. https://doi.org/10.1111/jth.12813.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Neunert CE, Buchanan GR, Imbach P, et al. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008;112(10):4003–8. https://doi.org/10.1182/blood-2008-03-138487.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Wei Y, Ji XB, Wang YW, Wang JX, et al. High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial. Blood. 2016;127(3):296–302. https://doi.org/10.1182/blood-2015-07-659656.

    Article  CAS  PubMed  Google Scholar 

  21. Blanchette VS, Luke B, Andrew M, et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr. 1993;123(6):989–95. https://doi.org/10.1016/S0022-3476(05)80400-7.

    Article  CAS  PubMed  Google Scholar 

  22. Perez EE, Orange JS, Bonilla F, et al. Update on the use of immunoglobulin in human disease: a review of evidence. J Allergy Clin Immunol. 2017;139(3):S1–S46. https://doi.org/10.1016/j.jaci.2016.09.023.

    Article  CAS  PubMed  Google Scholar 

  23. Son DW, Jeon IS, Yang SW, Cho SH. A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in korean children. J Pediatr Hematol Oncol. 2008;30(8):598–601. https://doi.org/10.1097/MPH.0b013e31817541ba.

    Article  CAS  PubMed  Google Scholar 

  24. Tarantino MD, Madden RM, Fennewald DL, Patel CC, Bertolone SJ. Treatment of childhood acute immune thrombocytopenic purpura with anti- D immune globulin or pooled immune globulin. J Pediatr. 1999;134(1):21–6. https://doi.org/10.1016/S0022-3476(99)70367-7.

    Article  CAS  PubMed  Google Scholar 

  25. Alioglu B, Avci Z, Ozyurek E, Ozbek N. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia. J Pediatr Hematol Oncol. 2007;29(9):636–9. https://doi.org/10.1097/MPH.0b013e318142ac5f.

    Article  CAS  PubMed  Google Scholar 

  26. Gaines AR. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rho(D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood. 2005;106(5):1532–7. https://doi.org/10.1182/blood-2004-11-4303.

    Article  CAS  PubMed  Google Scholar 

  27. Beck CE, et al. Corticosteroids Versus Intravenous Immune Globulin for the Treatment of Acute Immune Thrombocytopenic Purpura in Children: A Systemic Review and Meta-Analysis of Randomized Controlled Trials. The Journal of Pediatrics. 2005;147(4):521–27.

    Google Scholar 

  28. Gebauer E, Vijatov G. Idiopathic thrombocytopenic purpura in children. Med Pregl. 1998;51(3–4):127–34.

    CAS  PubMed  Google Scholar 

  29. Bennett CM, Rogers ZR, Kinnamon DD, et al. Brief report Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood. 2019;107(7):2639–43. https://doi.org/10.1182/blood-2005-08-3518.A.

    Article  Google Scholar 

  30. Bennett CM, Rogers ZR, Kinnamon DD, et al. Chronic immune thrombocytopenic purpura Brief report Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Child A Glob J Child Res. 2011;107(7):2639–42. https://doi.org/10.1182/blood-2005-08-3518.

    Article  CAS  Google Scholar 

  31. Wang J, Wiley JM, Luddy R, Greenberg J, Feuerstein MA, Bussel JB. Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment. J Pediatr. 2005;146(2):217–21. https://doi.org/10.1016/j.jpeds.2004.09.004.

    Article  CAS  PubMed  Google Scholar 

  32. Zaja F, Baccarani M, Mazza P, Bocchia M, Gugliotta L, Zaccaria A, Vianelli N, Defina M, Tieghi A, Amadori S, Campagna S. Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood. 2010;115(14):2755–62. https://doi.org/10.1182/blood-2009-07-229815. LK - http://sfx.library.uu.nl/utrecht?sid=EMBASE&issn=00064971&id=doi:10.1182%2Fblood-2009-07-229815&atitle=Dexamethasone+plus+rituximab+yields+higher+sustained+response+rates+than+dexamethasone+monotherapy+in+adults+with+primary+immune+thrombocytopenia&stitle=Blood&title=Blood&volume=115&issue=14&spage=2755&epage=2762&aulast=Zaja&aufirst=Francesco&auinit=F.&aufull=Zaja+F.&coden=BLOOA&isbn=&pages=2755-2762&date=2010&auinit1=F&auinitm=

    Article  CAS  PubMed  Google Scholar 

  33. Elgebaly AS, El Ashal G, Elfil M, Menshawy A. Tolerability and efficacy of eltrombopag in chronic immune thrombocytopenia: meta-analysis of randomized controlled trials. Clin Appl Thromb. 2017;23(8):928–37. https://doi.org/10.1177/1076029616663849.

    Article  CAS  Google Scholar 

  34. Saleh MN, Bussel JB, Cheng G, et al. Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. Blood. 2013;121(3):537–45. https://doi.org/10.1182/blood-2012-04-425512.

    Article  CAS  PubMed  Google Scholar 

  35. Guo JC, Zheng Y, Chen HT, et al. Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenia: a metaanalysis. Oncotarget. 2018;9(6):7112–25. https://doi.org/10.18632/oncotarget.23487.

    Article  PubMed  Google Scholar 

  36. Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB. Thrombopoietin receptor agonists: ten years later. Haematologica. 2019;104(6):1112–23. https://doi.org/10.3324/haematol.2018.212845.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Imbach P, Kühne T, Müller D, et al. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer. 2006;46(3):351–6. https://doi.org/10.1002/pbc.20453.

    Article  CAS  PubMed  Google Scholar 

  38. Zeller B, Rajantie J, Hedlund-Treutiger I, et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr Int J Paediatr. 2005;94(2):178–84. https://doi.org/10.1080/08035250410025294.

    Article  Google Scholar 

  39. Ahmed S, Siddiqui AK, Shahid RK, Kimpo M, Sison CP, Hoffman MA. Prognostic variables in newly diagnosed childhood immune thrombocytopenia. Am J Hematol. 2004;77(4):358–62. https://doi.org/10.1002/ajh.20205.

    Article  PubMed  Google Scholar 

  40. Bruin M, Bierings M, Uiterwaal C, et al. Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: results of a prospective study. Br J Haematol. 2004;127(5):561–7. https://doi.org/10.1111/j.1365-2141.2004.05235.x.

    Article  PubMed  Google Scholar 

  41. Bennett CM, Neunert C, Grace RF, et al. Predictors of remission in children with newly diagnosed immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group Registry II participants. Pediatr Blood Cancer. 2018;65(1):1–7. https://doi.org/10.1002/pbc.26736.

    Article  CAS  Google Scholar 

  42. Silver RM, Richard L. Thrombocytopenia in pregnancy. Gynecology. 1999;67:117–28.

    Google Scholar 

  43. Webert KE, Mittal R, Sigouin C, et al. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura a retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 2011;102(13):4306–11. https://doi.org/10.1182/blood-2002-10-3317.

    Article  CAS  Google Scholar 

  44. Al-Jama FE, Rahman J, Al-Suleiman SA, Rahman MS. Outcome of pregnancy in women with idiopathic thrombocytopenic purpura. Aust New Zeal J Obstet Gynaecol. 1998;38(4):410–3. https://doi.org/10.1111/j.1479-828X.1998.tb03099.x.

    Article  CAS  Google Scholar 

  45. Nicolescu A, Vladareanu AM, Voican I, Onisai M, Vladareanu R. Therapeutic options for immune thrombocytopenia (ITP) during pregnancy. Maedica (Buchar). 2013;8(2):182–8. http://www.ncbi.nlm.nih.gov/pubmed/24371483%0A. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3865128.

    Google Scholar 

  46. Anglin BV, Rutherford C, Ramus R, Lieser M, Jones DB. Immune thrombocytopenic purpura during pregnancy: laparoscopic treatment. JSLS. 2001;5(1):63–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Sainio S, Kekomäki R, Riikonen S, Teramo K. Maternal thrombocytopenai at term: a population-based study. Acta Obstet Gynecol Scand. 2000;79(9):744–9. https://doi.org/10.1034/j.1600-0412.2000.079009744.x.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Anna Griffith & Alice D. Ma

Authors
  1. Anna Griffith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alice D. Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alice D. Ma .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA

    Lakshmi V. Srivaths

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Griffith, A., Ma, A.D. (2020). Immune Thrombocytopenia in Adolescents. In: Srivaths, L. (eds) Hematology in the Adolescent Female. Springer, Cham. https://doi.org/10.1007/978-3-030-48446-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-48446-0_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-48445-3

  • Online ISBN: 978-3-030-48446-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation